Open randomized intergroup trial about efficacy and the safety of minodronate raloxifene and eldecalcitol in the drug choice after teriparatide 24 months administration for osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Minodronic acid (Primary) ; Eldecalcitol; Raloxifene
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 15 Mar 2018 Status changed from recruiting to completed.
- 10 Apr 2013 New trial record